Literature DB >> 11680530

Animal models of sepsis.

H Freise1, U B Brückner, H U Spiegel.   

Abstract

Knowledge of sepsis is growing rapidly and new pathogenetic concepts and therapeutic strategies evolve. The animal models of sepsis catalyze this development. Any model of this complex disease is inevitably a compromise between clinical realism and experimental simplification. Against the background of current pathogenetic concepts this review tries to analyze the validity and clinical relevance of each model. Endotoxemia and bacteremia represent models without an infectious focus. They reproduce many characteristics of sepsis and are highly controlled and standardized. However, they reflect a primarily systemic challenge and create neither an infectious focus nor the protracted immune reaction that characterizes sepsis. In this respect, any model with an infectious focus is decisively closer to clinical reality. In these models the peritoneal cavity is contaminated either by bacteria or inoculated feces or perforation of the bowel wall. Both the bolus injection and the implantation of carriers loaded with bacteria or feces are used. In fecal spesis and perforation models the complete spectrum of enteric pathogens is present in the septic focus and infective selection is undisturbed. Here the pathophysiologic and immunologic features of clinical sepsis are successfully reproduced. However, presumably due to inadequate control of the bacterial challenge, only poor interlaboratory standardization is possible. As to optimize models for the clinical reality the choice of an appropriate class of models is crucial. Moreover the incorporation of clinical therapy such as volume resuscitation, antibiotic therapy and surgical treatment of the septic focus is indispensable. Finally, the importance of simulation of comorbidities cannot be overemphasized.

Entities:  

Mesh:

Year:  2001        PMID: 11680530     DOI: 10.1080/089419301750420232

Source DB:  PubMed          Journal:  J Invest Surg        ISSN: 0894-1939            Impact factor:   2.533


  15 in total

1.  Antioxidant therapy in sepsis.

Authors:  Gerd Albuszies; Uwe Bernd Brückner
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

Review 2.  Modeling sepsis in the laboratory: merging sound science with animal well-being.

Authors:  Jean A Nemzek; Kelly M S Hugunin; Mark R Opp
Journal:  Comp Med       Date:  2008-04       Impact factor: 0.982

3.  mRNA and Long Non-coding RNA Expression Profiles in Rats Reveal Inflammatory Features in Sepsis-Associated Encephalopathy.

Authors:  WenChong Sun; Ling Pei; Zuodi Liang
Journal:  Neurochem Res       Date:  2017-08-07       Impact factor: 3.996

4.  Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice.

Authors:  M L Kruzel; Y Harari; D Mailman; J K Actor; M Zimecki
Journal:  Clin Exp Immunol       Date:  2002-10       Impact factor: 4.330

5.  Effects of thoracic epidural anaesthesia on intestinal microvascular perfusion in a rodent model of normotensive endotoxaemia.

Authors:  Jörn Adolphs; Diego K Schmidt; Ines Korsukewitz; Britta Kamin; Helmut Habazettl; Michael Schäfer; Martin Welte
Journal:  Intensive Care Med       Date:  2004-08-26       Impact factor: 17.440

Review 6.  Animal models of anemia of inflammation.

Authors:  Seth Rivera; Tomas Ganz
Journal:  Semin Hematol       Date:  2009-10       Impact factor: 3.851

7.  The role of speckle tracking echocardiography in assessment of lipopolysaccharide-induced myocardial dysfunction in mice.

Authors:  Ming Chu; Yao Gao; Yanjuan Zhang; Bin Zhou; Bingruo Wu; Jing Yao; Di Xu
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

8.  Effect of polymyxin B-immobilized fiber hemoperfusion on respiratory impairment, hepatocellular dysfunction, and leucopenia in a neonatal sepsis model.

Authors:  Mohamed Hamed Hussein; Ghada A Daoud; Hiroki Kakita; Shin Kato; Tatenobu Goto; Michi Kamei; Kenji Goto; Yasuhiko Ozaki; Tetsuya Ito; Sumio Fukuda; Ineko Kato; Satoshi Suzuki; Takashi Hashimoto; Hajime Togari
Journal:  Pediatr Surg Int       Date:  2009-10-03       Impact factor: 1.827

Review 9.  Animal models of sepsis and sepsis-induced kidney injury.

Authors:  Kent Doi; Asada Leelahavanichkul; Peter S T Yuen; Robert A Star
Journal:  J Clin Invest       Date:  2009-10-01       Impact factor: 14.808

10.  Cardiac effects of induction agents in the septic rat heart.

Authors:  York A Zausig; Hendrik Busse; Dirk Lunz; Barbara Sinner; Wolfgang Zink; Bernhard M Graf
Journal:  Crit Care       Date:  2009-09-08       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.